Unlisted share space on a high as investor interest grows

By Surender Negi

With interest in the unlisted space growing, several smaller firms are deploying innovative ways to tap small investors. These include benchmarks to track the direction of the unlisted space, like the Sensex and the Nifty, and low-ticket investment value.

There are at least two benchmarks for the unlisted space, first of which is by a company called Wealth Wisdom India with 40 stocks in its Primex 40 Index. As per information available on its website, the index was launched in 2023 with a base of 10,000 and is currently at 3,794, a 2.27x appreciation in about 19 months of its existence. The company claims that the index is the country’s first live private market index, with real-time prices of the shares, pretty much like the listed space.

Also ReadForward premium rates highest since March 2022

Some of the well-known names in the index include Boat, Capgemini, NSE India, Tata Capital, and PharmEasy. The weightage of the stocks in the basket is capped at 10% to prevent excessive concentration and promote diversification.

Another such index is Sharecart Private Market Index (SPMI), which started with a base of 1,000 around 2022 and is currently at 1,592. Stocks such as NSDL, Oyo, Chennai Super Kings and Bira are available for trade on the platform. 

Both these indices hit their lifetime highs during this week. Primex 40 Index clocked over 80% returns last year, while for Sharecart Index, it was nearly 40%. In comparison, the Sensex and the Nifty posted returns of 8.17% and 8.8%, respectively, in 2024.

According to a recent report, monthly trading volumes for unlisted shares grew up to 6x from $50-60 million in 2023 to $300 million in 2024. However, those trying to make a quick buck in the unlisted space should be wary of the pitfalls as the space is unregulated.

“Sharescart is not an investment advisory portal and does not make any investment recommendations and therefore does not require any licence from SEBI/RBI or regulatory authority in India. Investors are advised to use the data at their own risks,” its website states.

Markets regulator SEBI, which has been proactively keeping a tab on the space, said in December that “such activities (transaction in unlisted shares) are in violation of Securities Contract (Regulation) Act,

 » Read More

Related Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs. 3,230 Cr, up by 24% YoY and domestic revenue at INR 2,773 Cr, up 17%, Exports at INR 457 Cr, up 121% YoY. The company’s